 If you are a doctor or therapist please Email Us
PLASMA LIPIDS MANAGEMENT SOLUTION
Description
OMEDHA™ (docosahexaenoic acid) 1200mg is a dietary supplement manufactured for doctor’s and therapist’s practices and small group practices, to support partners and providers with an integrative solution for lowering their patient's high triglyceride levels.*
OMEDHA™ (docosahexaenoic acid) 1200mg is an innovative plasma sufficiency therapy. OMEDHA™ gives an option instead of fish oil formulations. OMEDHA™ gives the benefits of fish oil, but OMEDHA™is derived from plant based algae oil. Algae are the producers of OMEDHA™. OMEDHA™ is made using 100% certified self-contained processes for culturing and harnessing the golden oil (cGMP). OMEDHA™ is encapsulated in pure algae carrageenan softgels (cGMP) for use in clinical therapy programs to help lower high triglyceride levels by up to 26% when dosages are above 1 gram docosahexaenoic acid per day. [1,2].
Background
Docosahexaenoic acid is naturally found in human breast milk and is in every cell of the body. Certain tissues are rich in this structural and functional lipid. Studies have shown that docosahexaenoic acid provides cognitive and visual acuity benefits for the developing fetus and for aging adult’s supports a healthy brain, eyes and heart.
In addition, subjects taking algae oil omega-3 DHA daily had significant improvements in plasma lipids observed across 16 clinical studies and supported by two reviews, one by Source-Omega Founder and one by Martek Biosciences Corporation researchers [1,2].
“Data collected from consumer results report therapeutic benefits with 1200 mg docosahexaenoic acid daily. Pre-qualified subjects with high triglycerides (>200 mg/dl) volunteered for follow-up. Working with their doctors, the dosage provided 10% to 29% reduction in high triglyceride levels” reports Scott Doughman, Ph.D., the President and Chief Scientific Officer at Source-Omega and Founder of THINC HEALTH ASSOCIATES. 
Discussion
Dr. Doughman also proposes the significance of these findings, saying “The docosahexaenoic acid level in LOVAZA** by GSK is perhaps the most active ingredient for lowering high triglycerides. Our research and development at Source-Omega suggests that DHA is also more effective than fish oil mixtures for lowering postprandial triglycerides, an emerging topic in the area of diabetic dyslipidemia [Patent Pending]”
Contact Us
Source-Omega Press Contact: Gene Wolf 919-360-5275
|
|
Physicians' Education Resource: How to work with OMEDHA™
Sign-up for our Newsletter Lipid Clinic Reviews™ |
OMEDHA™ in Combination with Prescription Medications
OMEDHA™ is not to replace a doctor's direct advice or any form of prescribed medication. However, it is perfectly safe to combine OMEDHA™ with medications you may be using.* Combining nutraceutical dietary supplements and medications to increase benefits is not a new concept in healthcare. To address issues of cognitive function due to aging, diabetes, high blood pressure, doctors often combine medications and nutritional products so patients may derive benefits from compounds that target different aspects of a potential disease in order to preserve health and wellness. OMEDHA has no known drug interactions and is certified GRAS safety designations.
OMEDHA™ MADE EASY and SAFE
OMEDHA™ may be a strategy to consider with your patients.
OMEDHA™, gives you peace-of-mind, you are ensured and you know you are using the first natural docosahexaenic acid product to target plasma lipids.*** OMEDHA™ also ends possible docosahexaenoic acid deficiencies, supports cognitive health, and co-therapeutic strategies.
***OMEDHA™ (docosahexaenoic acid) 1200 mg is considered a protective strategy for cardiovascular, metabolic, and cognitive health. OMEDHA™ is not presently a treatment or a cure for any condition-specific disease. Heart health and triglyceride lowering benefits have been well studied and result in consistent findings. Independent research discussed is not directly based on OMEDHA™.
*Information and statements regarding this supplement have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.
|
FDA Announces Qualified Health Claims for Omega-3 Fatty Acids. The Food and Drug Administration (FDA) has announced the availability of a qualified health claim for reduced risk of coronary heart disease (CHD) on conventional foods that contain both eicosapentaenoic acid and docosahexaenoic acid omega-3 fatty acids,
Company Disclaimer: The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. Source-Omega, LLC encourages health care decisions based upon research in partnership with a qualified health care professional. All modalities are based on a dietary supplement strategy for increasing docosahexaenoic acid levels in the body, which requires sufficient levels for the minimum duration of 3-months in order to properly improve risk factors.
Manufactured by Source-Omega, LLC. 52 Norwood Rd. Chapel Hill, N.C. 27516 USA
|
|
